News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Alspaugh Jonathan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| Alspaugh Jonathan (President and CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 19,787,969 options to buy
@ $0.3, valued at
$5.9M
|
|
| 02/24/2023 |
4
| Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 640,000 options to buy
@ $0.44, valued at
$281.6k
|
|
| 08/25/2022 |
4
| Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $0.68, valued at
$88.4k
|
|
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|